nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—HTR2A—coronary artery disease	0.234	1	CbGaD
Methotrimeprazine—CYP1A2—Gemfibrozil—coronary artery disease	0.0398	0.184	CbGbCtD
Methotrimeprazine—CYP1A2—Clopidogrel—coronary artery disease	0.0345	0.16	CbGbCtD
Methotrimeprazine—CYP2D6—Niacin—coronary artery disease	0.0215	0.0998	CbGbCtD
Methotrimeprazine—CYP2D6—Timolol—coronary artery disease	0.02	0.0928	CbGbCtD
Methotrimeprazine—CYP2D6—Captopril—coronary artery disease	0.0176	0.0817	CbGbCtD
Methotrimeprazine—CYP2D6—Simvastatin—coronary artery disease	0.017	0.0789	CbGbCtD
Methotrimeprazine—CYP1A2—Losartan—coronary artery disease	0.0169	0.0781	CbGbCtD
Methotrimeprazine—CYP2D6—Pravastatin—coronary artery disease	0.0167	0.0772	CbGbCtD
Methotrimeprazine—CYP2D6—Lovastatin—coronary artery disease	0.0167	0.0772	CbGbCtD
Methotrimeprazine—CYP2D6—Atorvastatin—coronary artery disease	0.0152	0.0703	CbGbCtD
Methotrimeprazine—Sudden death—Eplerenone—coronary artery disease	0.00447	0.0218	CcSEcCtD
Methotrimeprazine—Drug interaction—Gemfibrozil—coronary artery disease	0.00344	0.0168	CcSEcCtD
Methotrimeprazine—HTR2A—arteriole—coronary artery disease	0.00319	0.137	CbGeAlD
Methotrimeprazine—Drug interaction—Rosuvastatin—coronary artery disease	0.00303	0.0148	CcSEcCtD
Methotrimeprazine—Liver injury—Clopidogrel—coronary artery disease	0.00285	0.0139	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Acetylsalicylic acid—coronary artery disease	0.00273	0.0133	CcSEcCtD
Methotrimeprazine—Photosensitivity—Gemfibrozil—coronary artery disease	0.00264	0.0129	CcSEcCtD
Methotrimeprazine—Drug interaction—Fenofibrate—coronary artery disease	0.00263	0.0128	CcSEcCtD
Methotrimeprazine—Drug interaction—Clopidogrel—coronary artery disease	0.00258	0.0126	CcSEcCtD
Methotrimeprazine—Drug interaction—Ezetimibe—coronary artery disease	0.00252	0.0123	CcSEcCtD
Methotrimeprazine—Jaundice—Pitavastatin—coronary artery disease	0.00246	0.012	CcSEcCtD
Methotrimeprazine—Drug interaction—Simvastatin—coronary artery disease	0.0024	0.0117	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Ezetimibe—coronary artery disease	0.00234	0.0114	CcSEcCtD
Methotrimeprazine—Drug interaction—Valsartan—coronary artery disease	0.00227	0.0111	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Simvastatin—coronary artery disease	0.00223	0.0109	CcSEcCtD
Methotrimeprazine—Liver injury—Captopril—coronary artery disease	0.00222	0.0108	CcSEcCtD
Methotrimeprazine—Drug interaction—Pravastatin—coronary artery disease	0.00217	0.0106	CcSEcCtD
Methotrimeprazine—Drug interaction—Enalapril—coronary artery disease	0.0021	0.0102	CcSEcCtD
Methotrimeprazine—HTR2A—pulmonary artery—coronary artery disease	0.00209	0.0898	CbGeAlD
Methotrimeprazine—HTR2A—sympathetic nervous system—coronary artery disease	0.00203	0.0874	CbGeAlD
Methotrimeprazine—Photosensitivity—Fenofibrate—coronary artery disease	0.00202	0.00983	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Pravastatin—coronary artery disease	0.00201	0.00982	CcSEcCtD
Methotrimeprazine—Drug interaction—Captopril—coronary artery disease	0.00201	0.00982	CcSEcCtD
Methotrimeprazine—HTR2A—vagus nerve—coronary artery disease	0.00197	0.0846	CbGeAlD
Methotrimeprazine—Photosensitivity—Lovastatin—coronary artery disease	0.00197	0.0096	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Penbutolol—coronary artery disease	0.00195	0.00953	CcSEcCtD
Methotrimeprazine—Drug interaction—Perindopril—coronary artery disease	0.00195	0.00953	CcSEcCtD
Methotrimeprazine—Photosensitivity—Ezetimibe—coronary artery disease	0.00193	0.00941	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Telmisartan—coronary artery disease	0.00192	0.00936	CcSEcCtD
Methotrimeprazine—HTR2A—vein—coronary artery disease	0.0019	0.0817	CbGeAlD
Methotrimeprazine—Drug interaction—Furosemide—coronary artery disease	0.0019	0.00926	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Captopril—coronary artery disease	0.00187	0.00911	CcSEcCtD
Methotrimeprazine—Photosensitivity—Simvastatin—coronary artery disease	0.00184	0.00897	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Gemfibrozil—coronary artery disease	0.00183	0.00892	CcSEcCtD
Methotrimeprazine—Jaundice—Gemfibrozil—coronary artery disease	0.00174	0.00849	CcSEcCtD
Methotrimeprazine—Photosensitivity—Valsartan—coronary artery disease	0.00174	0.00848	CcSEcCtD
Methotrimeprazine—Liver injury—Ramipril—coronary artery disease	0.00173	0.00845	CcSEcCtD
Methotrimeprazine—Photosensitivity—Pravastatin—coronary artery disease	0.00166	0.00811	CcSEcCtD
Methotrimeprazine—Photosensitivity—Trandolapril—coronary artery disease	0.00162	0.00788	CcSEcCtD
Methotrimeprazine—Photosensitivity—Enalapril—coronary artery disease	0.00161	0.00785	CcSEcCtD
Methotrimeprazine—Drug interaction—Ramipril—coronary artery disease	0.00157	0.00766	CcSEcCtD
Methotrimeprazine—Photosensitivity—Captopril—coronary artery disease	0.00154	0.00753	CcSEcCtD
Methotrimeprazine—Jaundice—Rosuvastatin—coronary artery disease	0.00153	0.00747	CcSEcCtD
Methotrimeprazine—Drowsiness—Acetylsalicylic acid—coronary artery disease	0.00153	0.00744	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Eplerenone—coronary artery disease	0.00152	0.00739	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Ramipril—coronary artery disease	0.00146	0.00711	CcSEcCtD
Methotrimeprazine—Photosensitivity—Furosemide—coronary artery disease	0.00146	0.0071	CcSEcCtD
Methotrimeprazine—DRD4—heart—coronary artery disease	0.00145	0.0625	CbGeAlD
Methotrimeprazine—Drug interaction—Lisinopril—coronary artery disease	0.00143	0.00695	CcSEcCtD
Methotrimeprazine—Urinary retention—Niacin—coronary artery disease	0.00141	0.00688	CcSEcCtD
Methotrimeprazine—Photosensitivity—Losartan—coronary artery disease	0.00141	0.00685	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Fenofibrate—coronary artery disease	0.0014	0.00681	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Valsartan—coronary artery disease	0.00139	0.0068	CcSEcCtD
Methotrimeprazine—Weight increased—Fenofibrate—coronary artery disease	0.00139	0.00679	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Tirofiban—coronary artery disease	0.00139	0.00677	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Olmesartan—coronary artery disease	0.00139	0.00676	CcSEcCtD
Methotrimeprazine—Constipation—Pitavastatin—coronary artery disease	0.00138	0.00671	CcSEcCtD
Methotrimeprazine—HTR2A—autonomic nervous system—coronary artery disease	0.00137	0.0587	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Lovastatin—coronary artery disease	0.00136	0.00665	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Niacin—coronary artery disease	0.00136	0.00661	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Ezetimibe—coronary artery disease	0.00134	0.00652	CcSEcCtD
Methotrimeprazine—Jaundice—Fenofibrate—coronary artery disease	0.00133	0.00648	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Enalapril—coronary artery disease	0.00129	0.00629	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Simvastatin—coronary artery disease	0.00128	0.00622	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Telmisartan—coronary artery disease	0.00127	0.00621	CcSEcCtD
Methotrimeprazine—Jaundice—Ezetimibe—coronary artery disease	0.00127	0.00621	CcSEcCtD
Methotrimeprazine—Urinary retention—Perindopril—coronary artery disease	0.00125	0.0061	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Clopidogrel—coronary artery disease	0.00125	0.0061	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Captopril—coronary artery disease	0.00124	0.00604	CcSEcCtD
Methotrimeprazine—Urinary retention—Furosemide—coronary artery disease	0.00122	0.00593	CcSEcCtD
Methotrimeprazine—Jaundice—Simvastatin—coronary artery disease	0.00121	0.00592	CcSEcCtD
Methotrimeprazine—Photosensitivity—Ramipril—coronary artery disease	0.00121	0.00588	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Valsartan—coronary artery disease	0.0012	0.00587	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Perindopril—coronary artery disease	0.0012	0.00586	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Olmesartan—coronary artery disease	0.0012	0.00584	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Pitavastatin—coronary artery disease	0.00119	0.00578	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Furosemide—coronary artery disease	0.00117	0.0057	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Pravastatin—coronary artery disease	0.00115	0.00562	CcSEcCtD
Methotrimeprazine—Weight increased—Pravastatin—coronary artery disease	0.00115	0.0056	CcSEcCtD
Methotrimeprazine—Jaundice—Olmesartan—coronary artery disease	0.00114	0.00556	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Losartan—coronary artery disease	0.00113	0.0055	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Trandolapril—coronary artery disease	0.00112	0.00546	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Enalapril—coronary artery disease	0.00112	0.00544	CcSEcCtD
Methotrimeprazine—Jaundice—Niacin—coronary artery disease	0.00111	0.00544	CcSEcCtD
Methotrimeprazine—Jaundice—Pravastatin—coronary artery disease	0.0011	0.00535	CcSEcCtD
Methotrimeprazine—Drowsiness—Trandolapril—coronary artery disease	0.00109	0.00533	CcSEcCtD
Methotrimeprazine—Photosensitivity—Lisinopril—coronary artery disease	0.00109	0.00533	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Olmesartan—coronary artery disease	0.00109	0.00533	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Captopril—coronary artery disease	0.00107	0.00521	CcSEcCtD
Methotrimeprazine—Jaundice—Enalapril—coronary artery disease	0.00106	0.00518	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Perindopril—coronary artery disease	0.00104	0.00506	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Trandolapril—coronary artery disease	0.00102	0.00498	CcSEcCtD
Methotrimeprazine—Jaundice—Captopril—coronary artery disease	0.00102	0.00496	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Enalapril—coronary artery disease	0.00102	0.00496	CcSEcCtD
Methotrimeprazine—Drowsiness—Perindopril—coronary artery disease	0.00101	0.00495	CcSEcCtD
Methotrimeprazine—Somnolence—Gemfibrozil—coronary artery disease	0.00101	0.00494	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Furosemide—coronary artery disease	0.00101	0.00492	CcSEcCtD
Methotrimeprazine—Jaundice—Perindopril—coronary artery disease	0.000989	0.00482	CcSEcCtD
Methotrimeprazine—Drowsiness—Furosemide—coronary artery disease	0.000986	0.00481	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Captopril—coronary artery disease	0.000975	0.00475	CcSEcCtD
Methotrimeprazine—Constipation—Gemfibrozil—coronary artery disease	0.000975	0.00475	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Losartan—coronary artery disease	0.000974	0.00475	CcSEcCtD
Methotrimeprazine—Weight increased—Losartan—coronary artery disease	0.000971	0.00473	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Ramipril—coronary artery disease	0.000967	0.00471	CcSEcCtD
Methotrimeprazine—Constipation—Ticagrelor—coronary artery disease	0.000952	0.00464	CcSEcCtD
Methotrimeprazine—Tachycardia—Acetylsalicylic acid—coronary artery disease	0.00095	0.00463	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Perindopril—coronary artery disease	0.000947	0.00461	CcSEcCtD
Methotrimeprazine—Jaundice—Losartan—coronary artery disease	0.000927	0.00452	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Furosemide—coronary artery disease	0.00092	0.00449	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Losartan—coronary artery disease	0.000888	0.00433	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Lisinopril—coronary artery disease	0.000877	0.00427	CcSEcCtD
Methotrimeprazine—Somnolence—Acetylsalicylic acid—coronary artery disease	0.000866	0.00422	CcSEcCtD
Methotrimeprazine—Constipation—Rosuvastatin—coronary artery disease	0.000857	0.00418	CcSEcCtD
Methotrimeprazine—Tachycardia—Fenofibrate—coronary artery disease	0.000849	0.00414	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Ramipril—coronary artery disease	0.000835	0.00407	CcSEcCtD
Methotrimeprazine—Weight increased—Ramipril—coronary artery disease	0.000833	0.00406	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Ticagrelor—coronary artery disease	0.00082	0.004	CcSEcCtD
Methotrimeprazine—Jaundice—Ramipril—coronary artery disease	0.000795	0.00388	CcSEcCtD
Methotrimeprazine—HTR2A—artery—coronary artery disease	0.000775	0.0333	CbGeAlD
Methotrimeprazine—Somnolence—Fenofibrate—coronary artery disease	0.000773	0.00377	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Ramipril—coronary artery disease	0.000761	0.00371	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Lisinopril—coronary artery disease	0.000757	0.00369	CcSEcCtD
Methotrimeprazine—Weight increased—Lisinopril—coronary artery disease	0.000755	0.00368	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Timolol—coronary artery disease	0.000744	0.00363	CcSEcCtD
Methotrimeprazine—Constipation—Fenofibrate—coronary artery disease	0.000744	0.00363	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Rosuvastatin—coronary artery disease	0.000738	0.0036	CcSEcCtD
Methotrimeprazine—Constipation—Clopidogrel—coronary artery disease	0.000731	0.00356	CcSEcCtD
Methotrimeprazine—Tachycardia—Olmesartan—coronary artery disease	0.000729	0.00355	CcSEcCtD
Methotrimeprazine—Constipation—Lovastatin—coronary artery disease	0.000726	0.00354	CcSEcCtD
Methotrimeprazine—Jaundice—Lisinopril—coronary artery disease	0.000721	0.00352	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.000717	0.0035	CcSEcCtD
Methotrimeprazine—Constipation—Ezetimibe—coronary artery disease	0.000712	0.00347	CcSEcCtD
Methotrimeprazine—Tachycardia—Niacin—coronary artery disease	0.000712	0.00347	CcSEcCtD
Methotrimeprazine—Clomipramine—HRH2—coronary artery disease	0.000707	0.121	CrCbGaD
Methotrimeprazine—Constipation—Eplerenone—coronary artery disease	0.000697	0.0034	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Lisinopril—coronary artery disease	0.00069	0.00337	CcSEcCtD
Methotrimeprazine—Tachycardia—Trandolapril—coronary artery disease	0.000681	0.00332	CcSEcCtD
Methotrimeprazine—Constipation—Simvastatin—coronary artery disease	0.000679	0.00331	CcSEcCtD
Methotrimeprazine—Tachycardia—Enalapril—coronary artery disease	0.000678	0.00331	CcSEcCtD
Methotrimeprazine—Tachycardia—Telmisartan—coronary artery disease	0.000669	0.00326	CcSEcCtD
Methotrimeprazine—Somnolence—Valsartan—coronary artery disease	0.000667	0.00325	CcSEcCtD
Methotrimeprazine—HTR2A—endothelium—coronary artery disease	0.000655	0.0281	CbGeAlD
Methotrimeprazine—Tachycardia—Captopril—coronary artery disease	0.00065	0.00317	CcSEcCtD
Methotrimeprazine—Somnolence—Niacin—coronary artery disease	0.000649	0.00316	CcSEcCtD
Methotrimeprazine—Constipation—Valsartan—coronary artery disease	0.000642	0.00313	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Fenofibrate—coronary artery disease	0.000641	0.00312	CcSEcCtD
Methotrimeprazine—ADRA2C—cardiac ventricle—coronary artery disease	0.000641	0.0275	CbGeAlD
Methotrimeprazine—Constipation—Olmesartan—coronary artery disease	0.000639	0.00311	CcSEcCtD
Methotrimeprazine—Tachycardia—Perindopril—coronary artery disease	0.000631	0.00308	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Clopidogrel—coronary artery disease	0.00063	0.00307	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Lovastatin—coronary artery disease	0.000626	0.00305	CcSEcCtD
Methotrimeprazine—Somnolence—Trandolapril—coronary artery disease	0.00062	0.00302	CcSEcCtD
Methotrimeprazine—Somnolence—Enalapril—coronary artery disease	0.000618	0.00301	CcSEcCtD
Methotrimeprazine—Constipation—Pravastatin—coronary artery disease	0.000614	0.00299	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Ezetimibe—coronary artery disease	0.000614	0.00299	CcSEcCtD
Methotrimeprazine—Somnolence—Telmisartan—coronary artery disease	0.000609	0.00297	CcSEcCtD
Methotrimeprazine—ADRA2C—myocardium—coronary artery disease	0.000603	0.0259	CbGeAlD
Methotrimeprazine—Constipation—Trandolapril—coronary artery disease	0.000596	0.00291	CcSEcCtD
Methotrimeprazine—Constipation—Enalapril—coronary artery disease	0.000594	0.0029	CcSEcCtD
Methotrimeprazine—Somnolence—Captopril—coronary artery disease	0.000592	0.00289	CcSEcCtD
Methotrimeprazine—Tachycardia—Losartan—coronary artery disease	0.000592	0.00289	CcSEcCtD
Methotrimeprazine—CHRM2—heart—coronary artery disease	0.00059	0.0254	CbGeAlD
Methotrimeprazine—Constipation—Telmisartan—coronary artery disease	0.000586	0.00286	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Simvastatin—coronary artery disease	0.000585	0.00285	CcSEcCtD
Methotrimeprazine—Somnolence—Perindopril—coronary artery disease	0.000575	0.0028	CcSEcCtD
Methotrimeprazine—Constipation—Captopril—coronary artery disease	0.00057	0.00278	CcSEcCtD
Methotrimeprazine—Somnolence—Furosemide—coronary artery disease	0.000559	0.00273	CcSEcCtD
Methotrimeprazine—CHRM2—cardiovascular system—coronary artery disease	0.000557	0.0239	CbGeAlD
Methotrimeprazine—Constipation—Perindopril—coronary artery disease	0.000553	0.0027	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Valsartan—coronary artery disease	0.000553	0.00269	CcSEcCtD
Methotrimeprazine—Somnolence—Losartan—coronary artery disease	0.000539	0.00263	CcSEcCtD
Methotrimeprazine—Constipation—Furosemide—coronary artery disease	0.000538	0.00262	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Niacin—coronary artery disease	0.000537	0.00262	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Pravastatin—coronary artery disease	0.000529	0.00258	CcSEcCtD
Methotrimeprazine—Constipation—Losartan—coronary artery disease	0.000519	0.00253	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Trandolapril—coronary artery disease	0.000514	0.00251	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Enalapril—coronary artery disease	0.000512	0.0025	CcSEcCtD
Methotrimeprazine—Tachycardia—Ramipril—coronary artery disease	0.000508	0.00248	CcSEcCtD
Methotrimeprazine—CHRM1—cardiovascular system—coronary artery disease	0.000507	0.0218	CbGeAlD
Methotrimeprazine—Hypersensitivity—Telmisartan—coronary artery disease	0.000505	0.00246	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Furosemide—coronary artery disease	0.000463	0.00226	CcSEcCtD
Methotrimeprazine—Somnolence—Ramipril—coronary artery disease	0.000463	0.00226	CcSEcCtD
Methotrimeprazine—Tachycardia—Lisinopril—coronary artery disease	0.000461	0.00225	CcSEcCtD
Methotrimeprazine—Somnolence—Timolol—coronary artery disease	0.000452	0.0022	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Losartan—coronary artery disease	0.000447	0.00218	CcSEcCtD
Methotrimeprazine—Constipation—Ramipril—coronary artery disease	0.000445	0.00217	CcSEcCtD
Methotrimeprazine—ADRA1A—heart—coronary artery disease	0.000441	0.019	CbGeAlD
Methotrimeprazine—ADRA2C—heart—coronary artery disease	0.000421	0.0181	CbGeAlD
Methotrimeprazine—Somnolence—Lisinopril—coronary artery disease	0.000419	0.00205	CcSEcCtD
Methotrimeprazine—ADRA1A—cardiovascular system—coronary artery disease	0.000416	0.0179	CbGeAlD
Methotrimeprazine—Constipation—Lisinopril—coronary artery disease	0.000404	0.00197	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Ramipril—coronary artery disease	0.000383	0.00187	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Timolol—coronary artery disease	0.000375	0.00183	CcSEcCtD
Methotrimeprazine—ADRA2C—cardiac atrium—coronary artery disease	0.00036	0.0155	CbGeAlD
Methotrimeprazine—Hypersensitivity—Lisinopril—coronary artery disease	0.000348	0.00169	CcSEcCtD
Methotrimeprazine—ADRA2A—heart—coronary artery disease	0.000336	0.0144	CbGeAlD
Methotrimeprazine—ADRA1A—blood—coronary artery disease	0.000329	0.0142	CbGeAlD
Methotrimeprazine—ADRA2C—blood—coronary artery disease	0.000314	0.0135	CbGeAlD
Methotrimeprazine—CYP2E1—cardiovascular system—coronary artery disease	0.00031	0.0133	CbGeAlD
Methotrimeprazine—Clomipramine—GSTP1—coronary artery disease	0.000294	0.0502	CrCbGaD
Methotrimeprazine—ADRA2A—cardiac atrium—coronary artery disease	0.000287	0.0123	CbGeAlD
Methotrimeprazine—HTR2A—heart—coronary artery disease	0.000285	0.0123	CbGeAlD
Methotrimeprazine—CYP1A2—blood—coronary artery disease	0.000272	0.0117	CbGeAlD
Methotrimeprazine—HTR2A—cardiovascular system—coronary artery disease	0.000269	0.0116	CbGeAlD
Methotrimeprazine—Imipramine—SLC22A3—coronary artery disease	0.000258	0.0442	CrCbGaD
Methotrimeprazine—ADRA2A—blood—coronary artery disease	0.00025	0.0108	CbGeAlD
Methotrimeprazine—Cyamemazine—HTR2A—coronary artery disease	0.000248	0.0423	CrCbGaD
Methotrimeprazine—CYP2E1—blood—coronary artery disease	0.000245	0.0105	CbGeAlD
Methotrimeprazine—Diltiazem—CYP2C19—coronary artery disease	0.000238	0.0407	CrCbGaD
Methotrimeprazine—Thioridazine—HTR7—coronary artery disease	0.000227	0.0387	CrCbGaD
Methotrimeprazine—HTR2A—blood—coronary artery disease	0.000213	0.00915	CbGeAlD
Methotrimeprazine—Perphenazine—HTR7—coronary artery disease	0.000208	0.0355	CrCbGaD
Methotrimeprazine—CYP2D6—blood—coronary artery disease	0.000194	0.00834	CbGeAlD
Methotrimeprazine—Pipotiazine—CYP2C19—coronary artery disease	0.000189	0.0322	CrCbGaD
Methotrimeprazine—Chlorpromazine—HTR7—coronary artery disease	0.000165	0.0282	CrCbGaD
Methotrimeprazine—Imipramine—HTR7—coronary artery disease	0.000164	0.028	CrCbGaD
Methotrimeprazine—Acepromazine—HTR2A—coronary artery disease	0.000159	0.0272	CrCbGaD
Methotrimeprazine—Thioproperazine—HTR2A—coronary artery disease	0.000156	0.0266	CrCbGaD
Methotrimeprazine—Pipotiazine—HTR2A—coronary artery disease	0.000153	0.0261	CrCbGaD
Methotrimeprazine—Mesoridazine—HTR2A—coronary artery disease	0.000151	0.0258	CrCbGaD
Methotrimeprazine—Clomipramine—CYP2C19—coronary artery disease	0.000149	0.0255	CrCbGaD
Methotrimeprazine—Thioridazine—CYP2C19—coronary artery disease	0.000141	0.024	CrCbGaD
Methotrimeprazine—Trimipramine—CYP2C19—coronary artery disease	0.000137	0.0235	CrCbGaD
Methotrimeprazine—Fluphenazine—HTR2A—coronary artery disease	0.000132	0.0226	CrCbGaD
Methotrimeprazine—Perphenazine—CYP2C19—coronary artery disease	0.000129	0.022	CrCbGaD
Methotrimeprazine—Propiomazine—HTR2A—coronary artery disease	0.000127	0.0217	CrCbGaD
Methotrimeprazine—Clomipramine—HTR2A—coronary artery disease	0.000121	0.0207	CrCbGaD
Methotrimeprazine—Chlorprothixene—HTR2A—coronary artery disease	0.00012	0.0206	CrCbGaD
Methotrimeprazine—Promazine—CYP2C19—coronary artery disease	0.000116	0.0199	CrCbGaD
Methotrimeprazine—Thioridazine—HTR2A—coronary artery disease	0.000114	0.0195	CrCbGaD
Methotrimeprazine—Trimipramine—HTR2A—coronary artery disease	0.000111	0.019	CrCbGaD
Methotrimeprazine—Acepromazine—ALB—coronary artery disease	0.000109	0.0186	CrCbGaD
Methotrimeprazine—Promethazine—HTR2A—coronary artery disease	0.000107	0.0183	CrCbGaD
Methotrimeprazine—Thioproperazine—ALB—coronary artery disease	0.000106	0.0182	CrCbGaD
Methotrimeprazine—Trifluoperazine—HTR2A—coronary artery disease	0.000106	0.0181	CrCbGaD
Methotrimeprazine—Pipotiazine—ALB—coronary artery disease	0.000105	0.0179	CrCbGaD
Methotrimeprazine—Perphenazine—HTR2A—coronary artery disease	0.000105	0.0179	CrCbGaD
Methotrimeprazine—Imipramine—CYP2C19—coronary artery disease	0.000102	0.0174	CrCbGaD
Methotrimeprazine—Promazine—HTR2A—coronary artery disease	9.43e-05	0.0161	CrCbGaD
Methotrimeprazine—Chlorpromazine—HTR2A—coronary artery disease	8.29e-05	0.0142	CrCbGaD
Methotrimeprazine—Clomipramine—ALB—coronary artery disease	8.28e-05	0.0141	CrCbGaD
Methotrimeprazine—Imipramine—HTR2A—coronary artery disease	8.25e-05	0.0141	CrCbGaD
Methotrimeprazine—Chlorpromazine—ALB—coronary artery disease	5.68e-05	0.0097	CrCbGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	2.9e-06	9.17e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NOS3—coronary artery disease	2.9e-06	9.17e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	2.89e-06	9.14e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTGS2—coronary artery disease	2.89e-06	9.14e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NOS3—coronary artery disease	2.89e-06	9.14e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	2.88e-06	9.13e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	2.88e-06	9.12e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NOS3—coronary artery disease	2.88e-06	9.11e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	2.88e-06	9.1e-06	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TGFB1—coronary artery disease	2.87e-06	9.08e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—JAK2—coronary artery disease	2.87e-06	9.07e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	2.86e-06	9.06e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	2.85e-06	9.02e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	2.84e-06	8.99e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	2.84e-06	8.98e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	2.84e-06	8.98e-06	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TGFB1—coronary artery disease	2.83e-06	8.96e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.83e-06	8.95e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	2.82e-06	8.93e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	2.82e-06	8.92e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—JAK2—coronary artery disease	2.81e-06	8.91e-06	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—VEGFA—coronary artery disease	2.81e-06	8.91e-06	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MAPK1—coronary artery disease	2.81e-06	8.91e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	2.81e-06	8.89e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—JAK2—coronary artery disease	2.8e-06	8.88e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AGT—coronary artery disease	2.8e-06	8.87e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—JAK2—coronary artery disease	2.8e-06	8.85e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	2.79e-06	8.84e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	2.78e-06	8.82e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—VEGFA—coronary artery disease	2.78e-06	8.79e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	2.78e-06	8.79e-06	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MAPK1—coronary artery disease	2.78e-06	8.79e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—LPL—coronary artery disease	2.78e-06	8.79e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.77e-06	8.77e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	2.77e-06	8.77e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	2.77e-06	8.75e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	2.76e-06	8.75e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	2.76e-06	8.74e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	2.76e-06	8.74e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	2.76e-06	8.73e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	2.76e-06	8.73e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	2.75e-06	8.7e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—APOE—coronary artery disease	2.75e-06	8.69e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	2.74e-06	8.68e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	2.74e-06	8.68e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	2.74e-06	8.67e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	2.72e-06	8.6e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—APOA1—coronary artery disease	2.71e-06	8.59e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	2.71e-06	8.59e-06	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	2.71e-06	8.58e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GPX1—coronary artery disease	2.71e-06	8.57e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	2.71e-06	8.57e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	2.71e-06	8.57e-06	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—AKT1—coronary artery disease	2.7e-06	8.55e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	2.7e-06	8.54e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	2.69e-06	8.5e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	2.68e-06	8.49e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	2.68e-06	8.47e-06	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	2.66e-06	8.41e-06	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—coronary artery disease	2.65e-06	8.39e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	2.64e-06	8.37e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	2.64e-06	8.36e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CD36—coronary artery disease	2.64e-06	8.35e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	2.62e-06	8.28e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	2.61e-06	8.25e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	2.6e-06	8.24e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	2.6e-06	8.23e-06	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TGFB1—coronary artery disease	2.58e-06	8.18e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	2.57e-06	8.15e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	2.57e-06	8.13e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	2.57e-06	8.12e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	2.57e-06	8.12e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	2.56e-06	8.1e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	2.55e-06	8.08e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	2.55e-06	8.07e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TGFB1—coronary artery disease	2.55e-06	8.07e-06	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MAPK1—coronary artery disease	2.53e-06	8.02e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	2.53e-06	8.01e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	2.53e-06	8e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	2.53e-06	8e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	2.52e-06	7.98e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	2.51e-06	7.96e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	2.51e-06	7.94e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CASP3—coronary artery disease	2.5e-06	7.93e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	2.5e-06	7.91e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MAPK1—coronary artery disease	2.5e-06	7.91e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MTHFR—coronary artery disease	2.5e-06	7.91e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	2.49e-06	7.88e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL6—coronary artery disease	2.49e-06	7.87e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	2.49e-06	7.87e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	2.48e-06	7.85e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	2.47e-06	7.83e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	2.47e-06	7.8e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	2.46e-06	7.8e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CASP3—coronary artery disease	2.46e-06	7.78e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CASP3—coronary artery disease	2.45e-06	7.76e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	2.45e-06	7.75e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CASP3—coronary artery disease	2.44e-06	7.73e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL6—coronary artery disease	2.44e-06	7.73e-06	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	2.44e-06	7.73e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	2.44e-06	7.73e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CCND1—coronary artery disease	2.44e-06	7.71e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	2.43e-06	7.71e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL6—coronary artery disease	2.43e-06	7.71e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL6—coronary artery disease	2.43e-06	7.68e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	2.42e-06	7.66e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	2.41e-06	7.64e-06	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	2.41e-06	7.62e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	2.41e-06	7.62e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	2.4e-06	7.61e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	2.4e-06	7.59e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	2.4e-06	7.59e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CCND1—coronary artery disease	2.39e-06	7.57e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PPARG—coronary artery disease	2.39e-06	7.57e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CCND1—coronary artery disease	2.39e-06	7.55e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CCND1—coronary artery disease	2.38e-06	7.53e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AGT—coronary artery disease	2.37e-06	7.52e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MMP9—coronary artery disease	2.37e-06	7.49e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—POMC—coronary artery disease	2.36e-06	7.47e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	2.35e-06	7.45e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	2.35e-06	7.43e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	2.34e-06	7.41e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	2.34e-06	7.41e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	2.33e-06	7.37e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOE—coronary artery disease	2.33e-06	7.36e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MMP9—coronary artery disease	2.32e-06	7.35e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MMP9—coronary artery disease	2.32e-06	7.33e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MMP9—coronary artery disease	2.31e-06	7.31e-06	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	2.31e-06	7.3e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	2.3e-06	7.29e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	2.3e-06	7.28e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOA1—coronary artery disease	2.3e-06	7.28e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	2.29e-06	7.26e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	2.29e-06	7.24e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	2.28e-06	7.22e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	2.26e-06	7.16e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	2.26e-06	7.15e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	2.26e-06	7.14e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	2.25e-06	7.13e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	2.25e-06	7.11e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	2.24e-06	7.09e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	2.24e-06	7.09e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	2.23e-06	7.05e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	2.22e-06	7.02e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	2.21e-06	7e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	2.21e-06	6.99e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.2e-06	6.97e-06	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	2.2e-06	6.96e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PIK3CA—coronary artery disease	2.19e-06	6.92e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	2.18e-06	6.91e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	2.17e-06	6.86e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	2.17e-06	6.86e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	2.17e-06	6.86e-06	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL6—coronary artery disease	2.16e-06	6.84e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ALB—coronary artery disease	2.15e-06	6.81e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	2.15e-06	6.8e-06	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL6—coronary artery disease	2.13e-06	6.75e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	2.12e-06	6.73e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	2.12e-06	6.7e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	2.12e-06	6.7e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	2.11e-06	6.67e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	2.09e-06	6.62e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	2.09e-06	6.6e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	2.08e-06	6.58e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	2.07e-06	6.57e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	2.07e-06	6.56e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—NOS3—coronary artery disease	2.06e-06	6.51e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	2.05e-06	6.5e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	2.05e-06	6.5e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	2.05e-06	6.48e-06	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL6—coronary artery disease	2.04e-06	6.47e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARG—coronary artery disease	2.03e-06	6.41e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—POMC—coronary artery disease	2e-06	6.33e-06	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—AKT1—coronary artery disease	1.99e-06	6.31e-06	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—AKT1—coronary artery disease	1.97e-06	6.23e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	1.96e-06	6.2e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	1.95e-06	6.17e-06	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL6—coronary artery disease	1.95e-06	6.16e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PIK3CA—coronary artery disease	1.94e-06	6.13e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL6—coronary artery disease	1.92e-06	6.08e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL6—coronary artery disease	1.92e-06	6.08e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	1.92e-06	6.07e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.91e-06	6.06e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	1.91e-06	6.05e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	1.91e-06	6.04e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	1.9e-06	6.02e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	1.9e-06	6.02e-06	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—AKT1—coronary artery disease	1.88e-06	5.96e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	1.88e-06	5.96e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	1.88e-06	5.96e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.88e-06	5.96e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	1.88e-06	5.95e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	1.88e-06	5.95e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.88e-06	5.94e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	1.87e-06	5.92e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	1.87e-06	5.91e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	1.85e-06	5.85e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	1.84e-06	5.83e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	1.83e-06	5.79e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ALB—coronary artery disease	1.82e-06	5.77e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	1.8e-06	5.7e-06	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—AKT1—coronary artery disease	1.8e-06	5.68e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—AKT1—coronary artery disease	1.79e-06	5.66e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	1.78e-06	5.62e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	1.77e-06	5.61e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—AKT1—coronary artery disease	1.77e-06	5.61e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	1.75e-06	5.53e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—NOS3—coronary artery disease	1.74e-06	5.52e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL6—coronary artery disease	1.73e-06	5.49e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	1.71e-06	5.42e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL6—coronary artery disease	1.66e-06	5.27e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	1.66e-06	5.25e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	1.63e-06	5.17e-06	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PIK3CA—coronary artery disease	1.63e-06	5.16e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	1.63e-06	5.16e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.62e-06	5.14e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL6—coronary artery disease	1.62e-06	5.13e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	1.62e-06	5.12e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	1.6e-06	5.07e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	1.6e-06	5.06e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	1.6e-06	5.06e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.59e-06	5.05e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL6—coronary artery disease	1.59e-06	5.05e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—AKT1—coronary artery disease	1.58e-06	5.01e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	1.54e-06	4.86e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	1.49e-06	4.73e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	1.49e-06	4.7e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	1.47e-06	4.65e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL6—coronary artery disease	1.47e-06	4.65e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—AKT1—coronary artery disease	1.45e-06	4.59e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL6—coronary artery disease	1.45e-06	4.58e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL6—coronary artery disease	1.44e-06	4.57e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL6—coronary artery disease	1.44e-06	4.55e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL6—coronary artery disease	1.43e-06	4.54e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL6—coronary artery disease	1.42e-06	4.49e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL6—coronary artery disease	1.42e-06	4.48e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AKT1—coronary artery disease	1.36e-06	4.29e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	1.33e-06	4.22e-06	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—AKT1—coronary artery disease	1.33e-06	4.22e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AKT1—coronary artery disease	1.33e-06	4.21e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AKT1—coronary artery disease	1.33e-06	4.2e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AKT1—coronary artery disease	1.32e-06	4.19e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	1.32e-06	4.16e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	1.31e-06	4.15e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	1.31e-06	4.13e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	1.21e-06	3.84e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.16e-06	3.66e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	9.81e-07	3.1e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AKT1—coronary artery disease	9.46e-07	2.99e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AKT1—coronary artery disease	8.01e-07	2.54e-06	CbGpPWpGaD
